Topic: Advancements in Neuromuscular Disease Therapy 

Learning Objectives:

At the conclusion of this session, the participant should be able to:

• review new therapies approved for neuro-muscular conditions within the past 3 years. 

• discuss the indications, efficacy, and cost of newly approved therapies. 

• review the data and clinical trials that led to approval of therapies. 

Speaker:

Sukhraj Gill, MD, Resident, Geisinger - nothing to disclose